OUTCOMES OF COMMERCIAL AND IN-HOUSE ANTI CD19 CAR T-CELL THERAPY FOR RELAPSED/REFRACTORY B-CELL LYMPHOMA IN SINGAPORE

被引：0
|
作者：
Ong, Shin Yeu [1 ]
Krisnadi, Cindy [1 ]
Wang, Samuel Sherng Young [1 ]
Chen, Yun Xin [1 ]
Seng, Michaela Su-fern [2 ]
Soh, Shui Yen [2 ]
Chan, Esther Hian Li [3 ]
Hwang, William Ying Khee [1 ]
Ho, Aloysius Yew Leng [1 ]
Lim, Francesca Lorraine Wei Inng [1 ]
机构：
[1] Singapore Gen Hosp, Singapore, Singapore
[2] KK Womens & Childrens Hosp, Singapore, Singapore
[3] Natl Univ Canc Inst, Singapore, Singapore
来源：
BONE MARROW TRANSPLANTATION | 2024年 / 59卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P120
引用
收藏
页码：226 / 226
页数：1
相关论文
共 50 条
  • [21] Impact of CD19 CAR T-cell product type on outcomes in relapsed or refractory aggressive B-NHL
    Gauthier, Jordan
    Gazeau, Nicolas
    Hirayama, Alexandre, V
    Hill, Joshua A.
    Wu, Vicky
    Cearley, Aisling
    Perkins, Paula
    Kirk, Angela
    Shadman, Mazyar
    Chow, Victor A.
    Gopal, Ajay K.
    Dwinal, Alexandria Hodges
    Williamson, Staci
    Myers, Jessie
    Chen, Andy
    Nagle, Sarah
    Hayes-Lattin, Brandon
    Schachter, Levanto
    Maloney, David G.
    Turtle, Cameron J.
    Sorror, Mohamed L.
    Maziarz, Richard T.
    BLOOD, 2022, 139 (26) : 3722 - 3731
  • [22] Efficacy of CD19 directed therapies in patients with relapsed or refractory large b-cell lymphoma relapsing after CD19 directed chimeric antigen receptor T-cell therapy
    Iqbal, Madiha
    Jagadeesh, Deepa
    Chavez, Julio
    Khurana, Arushi
    Rosenthal, Allison
    Craver, Emily
    Epperla, Narendranath
    Li, Zhuo
    Isufi, Iris
    Awan, Farrukh T.
    Dholaria, Bhagirathbhai R.
    Maakaron, Joseph E.
    Sandoval-Sus, Jose D.
    Mishra, Rahul
    Saha, Aditi
    Annunzio, Kaitlin
    Bhaskar, Shakthi T.
    Sumransub, Nuttavut
    Fijalka, Andrew
    Ivanov, Stanislav A.
    Lin, Yi
    Kharfan-Dabaja, Mohamed A.
    BONE MARROW TRANSPLANTATION, 2024, 59 (02) : 211 - 216
  • [23] Optimized tandem CD19/CD20 CAR-engineered T cells in refractory/relapsed B-cell lymphoma
    Tong, Chuan
    Zhang, Yajing
    Liu, Yang
    Ji, Xingyu
    Zhang, Wenying
    Guo, Yelei
    Han, Xiao
    Ti, Dongdong
    Dai, Hanren
    Wang, Chunmeng
    Yang, Qingming
    Liu, Wanli
    Wang, Yao
    Wu, Zhiqiang
    Han, Weidong
    BLOOD, 2020, 136 (14) : 1632 - 1644
  • [24] Efficacy of CD19 directed therapies in patients with relapsed or refractory large b-cell lymphoma relapsing after CD19 directed chimeric antigen receptor T-cell therapy
    Madiha Iqbal
    Deepa Jagadeesh
    Julio Chavez
    Arushi Khurana
    Allison Rosenthal
    Emily Craver
    Narendranath Epperla
    Zhuo Li
    Iris Isufi
    Farrukh T. Awan
    Bhagirathbhai R. Dholaria
    Joseph E. Maakaron
    Jose D. Sandoval-Sus
    Rahul Mishra
    Aditi Saha
    Kaitlin Annunzio
    Shakthi T. Bhaskar
    Nuttavut Sumransub
    Andrew Fijalka
    Stanislav A. Ivanov
    Yi Lin
    Mohamed A. Kharfan-Dabaja
    Bone Marrow Transplantation, 2024, 59 : 211 - 216
  • [25] Disease Control Affects Outcomes of Patients with Relapsed Diffuse Large B Cell Lymphoma Treated with CD19 Directed CAR T-Cell Therapy
    Pan, Dorothy C.
    Hamid, Showkat
    Herr, Megan
    Attwood, Kristopher
    McCarthy, Philip L.
    Ross, Maureen
    Schofield, Grant
    Cortese, Matthew J.
    Lamonica, Dominick
    Wong, Jerry Thwin
    Fu, Kai
    Maslak, Peter
    Davila, Marco
    Brentjens, Renier
    Hernandez-Ilizaliturri, Francisco J.
    BLOOD, 2023, 142
  • [26] Anti-CD19 CAR T-Cell Therapy for B-Cell Non-Hodgkin Lymphoma
    Abramson, Jeremy S.
    TRANSFUSION MEDICINE REVIEWS, 2020, 34 (01) : 29 - 33
  • [27] CD19 CAR-T Cell Therapy in Children with Relapsed and Refractory B-ALL
    Molostova, Olga
    Shelikhova, Larisa
    Muzalevsky, Yakov
    Kazachenok, Alexey
    Khismatullina, Rimma
    Abugova, Julia
    Kurnikova, Elena
    Trakhtman, Pavel
    Pershin, Dmitry
    Zubachenko, Viktoria
    Fadeeva, Maria
    Popov, Alexander M.
    Illarionova, Olga
    Miakova, Natalia
    Litvinov, Dmitry
    Novichkova, Galina
    Maschan, Alexey
    Maschan, Michael
    BLOOD, 2021, 138
  • [28] CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim results
    Jae H. Park
    Karthik Nath
    Sean M. Devlin
    Craig S. Sauter
    M. Lia Palomba
    Gunjan Shah
    Parastoo Dahi
    Richard J. Lin
    Michael Scordo
    Miguel-Angel Perales
    Roni Shouval
    Ana Alarcon Tomas
    Elizabeth Cathcart
    Elena Mead
    Bianca Santomasso
    Andrei Holodny
    Renier J. Brentjens
    Isabelle Riviere
    Michel Sadelain
    Nature Medicine, 2023, 29 : 1710 - 1717
  • [29] Outcomes with loncastuximab tesirine following CAR T-cell therapy in patients with relapsed or refractory diffuse large B-cell lymphoma
    Epperla, Narendranath
    Lucero, Melanie
    Bailey, Tom
    Mirams, Laura
    Cheung, Jolenta
    Amet, Mona
    Milligan, Gary
    Chen, Lei
    BLOOD CANCER JOURNAL, 2024, 14 (01):
  • [30] CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim results
    Park, Jae H.
    Nath, Karthik
    Devlin, Sean M.
    Sauter, Craig S.
    Palomba, M. Lia
    Shah, Gunjan
    Dahi, Parastoo
    Lin, Richard J. J.
    Scordo, Michael
    Perales, Miguel-Angel
    Shouval, Roni
    Tomas, Ana Alarcon
    Cathcart, Elizabeth
    Mead, Elena
    Santomasso, Bianca
    Holodny, Andrei
    Brentjens, Renier J.
    Riviere, Isabelle
    Sadelain, Michel
    NATURE MEDICINE, 2023, 29 (07) : 1710 - +
12345